Obvio Health USA is focused on making clinical trials faster and more cost effective.
Obviohealth supported by SPRIM, a global leader of health-centric innovation, operating in 19 countries with over 500 professionals. SPRIM is made up of teams with deep medical and life sciences expertise, strong digital and IT capabilities and significant regulatory and research experience. SPRIM has a strong global track record of developing winning strategies and tactics to deliver tangible commercial results, including disruptive innovation initiatives, health claims and new market entries.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 8, 2021 | Series B | $19.25M | 1 | Novotech | — | Detail |